Overcoming pharmacokinetic problems in the treatment of Parkinson's disease.
Obeso
J A
JA
Department of Neurology, Clinica Universitaria-Medical School, University of Navarra, Pamplona, Spain.
Vaamonde
J
J
Grandas
F
F
Luquin
M R
MR
Rodriguez
M
M
Lera
G
G
Martínez-Lage
J M
JM
D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D007980:Levodopa / Q000493:pharmacokinetics; D010300:Parkinson Disease / Q000097:blood* / Q000188:drug therapy; D011954:Receptors, Dopamine / Q000187:drug effects
D000978:Antiparkinson Agents; D011954:Receptors, Dopamine; D007980:Levodopa